Our company was founded in July, 1993. It is a private enterprise engaged in manufacturing of bulk pharmaceutical materials, intermediate and solid preparation. It is a scientific and technological enterprise in Zhejiang Province, Taizhou 116 key enterprises, Taizhou high-tech enterprise. There are 1 trading company (Zhejiang Jiangbei Hongrui Import & Export Co., Ltd.) and 2 manufacturing enterprises of BPC and intermediates (Zhejiang Jiangbei Nanhai Pharmacy Co., Ltd., Linhai Jinqiao Chemical Co., Ltd.) under our head office.
Our company has developed bulk pharmaceuticals, intermediates and solid preparations in 7 series, including, cardiovascular drugs, nervous centralis drugs, gastrointestinal drugs, antiviral drugs, anti-infective drug, anticoagulant drugs and anti-osteoporosis drugs. We have self-managerial import & export authority. Our products are popular in China. And they have been exported to over 20 regions and countries, for example, Europe, America, Japan, South Korea, Brazil, India, Southeast Asia region.
Our company takes “integrity, keep improving, high-efficiency and innovation” as our quality policy”. We win support and trust from wide uses relying on high quality product and responsibility. We apply America FDA, EU EMA and WHO standards in operation, in order to improve production technique and quality control capacity. Simvastatin, atorvastatin and levetiracetam products have passed America FDA, EU CEP and official inspection of Japan, Korea and India. And they pass domestic new version GMP authentication.
more >
Year of Establishment:
1993
Total Assets(USD):
10,000,000 to 14,999,999
Total Number of Staff:
200 to 249
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
25,000,000 to 29,999,999
Main Sales Markets:
Central/South America,Western Europe,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: